Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Delayed Quote. Delayed Xetra - 01/19 11:35:23 am
37.115 EUR   -1.17%
01/19European ADRs Move Higher in Wednesday Trading
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/17Fresenius Kabi is committed to achieving Net Zero emissions by 2045
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius : Jefferies Virtual London Healthcare Conference (PDF, 6.06 MB)

11/17/2021 | 01:05pm EST

12th Annual Jefferies London Healthcare Conference

November 18, 2021

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing.

Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.

12th Annual Jefferies London Healthcare Conference, November 18, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

2

Agenda

01

Company Highlights

02

03

04

Strategic update

Financial review

Attachments

Q3/21 &

Outlook FY/21

12th Annual Jefferies London Healthcare Conference, November 18, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

3

A Global Leader in Health Care Products and Services

in sales (FY/2020)

€ 36.3 bn

Global presence in 100+

countries

Leading market

#1 positions

Long-term opportunities in growing, non-cyclicalmarkets

100 +

Employees

worldwide

(as of September 30,

2021) 314,000+

Strong financial performance and cash flow generation

12th Annual Jefferies London Healthcare Conference, November 18, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

4

Investment Highlights

Diversified healthcare Group

Leading positions in

Resilient business model

with four strong business

growing non-cyclical

based on megatrends

segments

markets

healthcare and demographics

Purpose-driven business

Strong financial

Reliable

delivers sustainable

performance and cash

dividend growth

contribution to society

flow generation

12th Annual Jefferies London Healthcare Conference, November 18, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Fresenius SE & Co. KGaA published this content on 17 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2021 17:59:14 UTC.


ę Publicnow 2021
All news about FRESENIUS SE & CO. KGAA
01/19European ADRs Move Higher in Wednesday Trading
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/17Fresenius Kabi is committed to achieving Net Zero emissions by 2045
AQ
01/17FRESENIUS SE : JP Morgan remains Neutral
MD
01/14European ADRs Move Higher in Friday Trading
MT
01/13Thyssenkrupp's hydrogen business gets KGaA structure
RE
01/11FRESENIUS SE : JP Morgan gives a Neutral rating
MD
01/10FRESENIUS : Helios acquires majority stake in U.S. fertility center
PU
01/04FRESENIUS : ODDO BHF Forum 2022
PU
01/04FRESENIUS SE : JP Morgan reaffirms its Neutral rating
MD
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Financials
Sales 2021 37 341 M 42 385 M 42 385 M
Net income 2021 1 828 M 2 075 M 2 075 M
Net Debt 2021 22 585 M 25 636 M 25 636 M
P/E ratio 2021 11,3x
Yield 2021 2,34%
Capitalization 20 727 M 23 524 M 23 527 M
EV / Sales 2021 1,16x
EV / Sales 2022 1,07x
Nbr of Employees 314 852
Free-Float 73,4%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 37,12 €
Average target price 48,62 €
Spread / Average Target 31,0%
EPS Revisions
Managers and Directors
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Head-Legal & Human Resources Director
Klaus-Peter MŘller Independent Member-Supervisory Board